Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidating Financial Information (Tables)

v3.10.0.1
Condensed Consolidating Financial Information (Tables)
9 Months Ended
Nov. 30, 2018
Condensed Financial Information Disclosure [Abstract]  
Condensed Consolidating Balance Sheet
 
Parent
Company
 
Subsidiary
Guarantors
 
Subsidiary
Nonguarantors
 
Eliminations
 
Consolidated
(in millions)
 
 
 
 
 
 
 
 
 
Condensed Consolidating Balance Sheet at November 30, 2018
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
5.4

 
$
2.4

 
$
122.8

 
$

 
$
130.6

Accounts receivable
436.5

 
341.3

 
59.4

 

 
837.2

Inventories
198.1

 
1,590.6

 
577.9

 
(168.6
)
 
2,198.0

Intercompany receivable
29,127.3

 
40,158.9

 
19,860.0

 
(89,146.2
)
 

Prepaid expenses and other
180.1

 
55.7

 
355.1

 
(118.2
)
 
472.7

Total current assets
29,947.4

 
42,148.9

 
20,975.2

 
(89,433.0
)
 
3,638.5

Property, plant and equipment
80.7

 
778.8

 
4,126.8

 

 
4,986.3

Investments in subsidiaries
29,562.7

 
514.5

 
6,337.2

 
(36,414.4
)
 

Goodwill

 
6,185.5

 
1,876.3

 

 
8,061.8

Intangible assets

 
714.3

 
2,593.5

 

 
3,307.8

Intercompany notes receivable
5,590.5

 
2,318.8

 

 
(7,909.3
)
 

Equity method investments
17.2

 
1.8

 
3,564.0

 

 
3,583.0

Other assets
39.1

 
1.9

 
4,294.7

 
(22.7
)
 
4,313.0

Total assets
$
65,237.6

 
$
52,664.5

 
$
43,767.7

 
$
(133,779.4
)
 
$
27,890.4

 
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Short-term borrowings
$
626.5

 
$

 
$
105.0

 
$

 
$
731.5

Current maturities of long-term debt
1,052.0

 
13.4

 
0.2

 

 
1,065.6

Accounts payable
60.6

 
402.3

 
419.8

 

 
882.7

Intercompany payable
40,102.2

 
31,342.1

 
17,701.9

 
(89,146.2
)
 

Other accrued expenses and liabilities
352.5

 
313.2

 
159.5

 
(141.6
)
 
683.6

Total current liabilities
42,193.8

 
32,071.0

 
18,386.4

 
(89,287.8
)
 
3,363.4

Long-term debt, less current maturities
11,754.0

 
18.0

 
0.5

 

 
11,772.5

Intercompany notes payable

 
4,987.0

 
2,922.3

 
(7,909.3
)
 

Other liabilities
33.1

 
543.0

 
681.1

 
(22.7
)
 
1,234.5

Total liabilities
53,980.9

 
37,619.0

 
21,990.3

 
(97,219.8
)
 
16,370.4

CBI stockholders’ equity
11,256.7

 
15,045.5

 
21,514.1

 
(36,559.6
)
 
11,256.7

Noncontrolling interests

 

 
263.3

 

 
263.3

Total stockholders’ equity
11,256.7

 
15,045.5

 
21,777.4

 
(36,559.6
)
 
11,520.0

Total liabilities and stockholders’ equity
$
65,237.6

 
$
52,664.5

 
$
43,767.7

 
$
(133,779.4
)
 
$
27,890.4

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parent
Company
 
Subsidiary
Guarantors
 
Subsidiary
Nonguarantors
 
Eliminations
 
Consolidated
(in millions)
 
 
 
 
 
 
 
 
 
Condensed Consolidating Balance Sheet at February 28, 2018
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
4.6

 
$
4.4

 
$
81.3

 
$

 
$
90.3

Accounts receivable
2.0

 
12.6

 
761.6

 

 
776.2

Inventories
184.3

 
1,537.5

 
546.6

 
(184.4
)
 
2,084.0

Intercompany receivable
27,680.0

 
37,937.5

 
18,940.8

 
(84,558.3
)
 

Prepaid expenses and other
138.4

 
77.7

 
311.0

 
(3.6
)
 
523.5

Total current assets
28,009.3

 
39,569.7

 
20,641.3

 
(84,746.3
)
 
3,474.0

Property, plant and equipment
76.2

 
775.7

 
3,937.8

 

 
4,789.7

Investments in subsidiaries
20,948.7

 
442.0

 
5,876.9

 
(27,267.6
)
 

Goodwill

 
6,185.5

 
1,897.6

 

 
8,083.1

Intangible assets

 
718.2

 
2,586.6

 

 
3,304.8

Intercompany notes receivable
6,236.4

 
2,435.4

 

 
(8,671.8
)
 

Equity method investments

 
1.9

 
119.6

 

 
121.5

Other assets
33.1

 
2.8

 
747.1

 
(17.4
)
 
765.6

Total assets
$
55,303.7

 
$
50,131.2

 
$
35,806.9

 
$
(120,703.1
)
 
$
20,538.7

 
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Short-term borrowings
$
266.9

 
$

 
$
479.9

 
$

 
$
746.8

Current maturities of long-term debt
7.1

 
15.0

 
0.2

 

 
22.3

Accounts payable
63.4

 
128.3

 
400.5

 

 
592.2

Intercompany payable
37,408.2

 
30,029.7

 
17,120.4

 
(84,558.3
)
 

Other accrued expenses and liabilities
356.2

 
199.3

 
150.5

 
(27.7
)
 
678.3

Total current liabilities
38,101.8

 
30,372.3

 
18,151.5

 
(84,586.0
)
 
2,039.6

Long-term debt, less current maturities
9,166.9

 
9.1

 
241.6

 

 
9,417.6

Intercompany notes payable

 
5,029.2

 
3,642.6

 
(8,671.8
)
 

Other liabilities
59.9

 
493.5

 
553.8

 
(17.4
)
 
1,089.8

Total liabilities
47,328.6

 
35,904.1

 
22,589.5

 
(93,275.2
)
 
12,547.0

CBI stockholders’ equity
7,975.1

 
14,227.1

 
13,200.8

 
(27,427.9
)
 
7,975.1

Noncontrolling interests

 

 
16.6

 

 
16.6

Total stockholders’ equity
7,975.1

 
14,227.1

 
13,217.4

 
(27,427.9
)
 
7,991.7

Total liabilities and stockholders’ equity
$
55,303.7

 
$
50,131.2

 
$
35,806.9

 
$
(120,703.1
)
 
$
20,538.7

Condensed Consolidating Statement of Comprehensive Income
 
Parent
Company
 
Subsidiary
Guarantors
 
Subsidiary
Nonguarantors
 
Eliminations
 
Consolidated
(in millions)
 
 
 
 
 
 
 
 
 
Condensed Consolidating Statement of Comprehensive Income for the Nine Months Ended November 30, 2018
Sales
$
2,263.2

 
$
5,757.6

 
$
2,891.6

 
$
(3,996.1
)
 
$
6,916.3

Excise taxes
(269.5
)
 
(318.5
)
 
(9.5
)
 

 
(597.5
)
Net sales
1,993.7

 
5,439.1

 
2,882.1

 
(3,996.1
)
 
6,318.8

Cost of product sold
(1,565.2
)
 
(4,062.8
)
 
(1,505.6
)
 
4,001.6

 
(3,132.0
)
Gross profit
428.5

 
1,376.3

 
1,376.5

 
5.5

 
3,186.8

Selling, general and administrative expenses
(425.5
)
 
(651.5
)
 
(180.0
)
 
17.1

 
(1,239.9
)
Operating income
3.0

 
724.8

 
1,196.5

 
22.6

 
1,946.9

Equity in earnings (losses) of equity method investees and subsidiaries
2,519.4

 
(25.3
)
 
494.4

 
(2,956.6
)
 
31.9

Unrealized net gain on securities measured at fair value

 

 
786.5

 

 
786.5

Net gain on sale of unconsolidated investment

 

 
99.8

 

 
99.8

Interest income
0.6

 

 
7.3

 

 
7.9

Intercompany interest income
198.4

 
487.2

 
3.7

 
(689.3
)
 

Interest expense
(240.2
)
 
(0.9
)
 
(15.4
)
 

 
(256.5
)
Intercompany interest expense
(411.5
)
 
(148.2
)
 
(129.6
)
 
689.3

 

Loss on extinguishment of debt
(1.7
)
 

 

 

 
(1.7
)
Income before income taxes
2,068.0

 
1,037.6

 
2,443.2

 
(2,934.0
)
 
2,614.8

(Provision for) benefit from income taxes
128.4

 
(248.4
)
 
(284.0
)
 
(1.1
)
 
(405.1
)
Net income
2,196.4


789.2

 
2,159.2

 
(2,935.1
)
 
2,209.7

Net income attributable to noncontrolling interests

 

 
(13.3
)
 

 
(13.3
)
Net income attributable to CBI
$
2,196.4

 
$
789.2

 
$
2,145.9

 
$
(2,935.1
)
 
$
2,196.4

 
 
 
 
 
 
 
 
 
 
Comprehensive income attributable to CBI
$
1,893.4

 
$
788.6

 
$
1,843.1

 
$
(2,631.7
)
 
$
1,893.4

 
 
 
 
 
 
 
 
 
 
Condensed Consolidating Statement of Comprehensive Income for the Nine Months Ended November 30, 2017
Sales
$
2,171.4

 
$
5,279.6

 
$
2,638.1

 
$
(3,698.5
)
 
$
6,390.6

Excise taxes
(263.2
)
 
(299.7
)
 
(9.4
)
 

 
(572.3
)
Net sales
1,908.2

 
4,979.9

 
2,628.7

 
(3,698.5
)
 
5,818.3

Cost of product sold
(1,524.4
)
 
(3,686.0
)
 
(1,350.6
)
 
3,710.0

 
(2,851.0
)
Gross profit
383.8

 
1,293.9

 
1,278.1

 
11.5

 
2,967.3

Selling, general and administrative expenses
(347.1
)
 
(661.0
)
 
(202.1
)
 
10.9

 
(1,199.3
)
Operating income
36.7

 
632.9

 
1,076.0

 
22.4

 
1,768.0

Equity in earnings (losses) of equity method investees and subsidiaries
1,524.8

 
(14.6
)
 
366.6

 
(1,844.0
)
 
32.8

Unrealized net gain on securities measured at fair value and related activities

 

 
216.9

 

 
216.9

Interest income
0.1

 

 
0.3

 

 
0.4

Intercompany interest income
177.1

 
365.2

 
3.3

 
(545.6
)
 

Interest expense
(198.6
)
 
(0.9
)
 
(46.0
)
 

 
(245.5
)
Intercompany interest expense
(293.1
)
 
(147.2
)
 
(105.3
)
 
545.6

 

Loss on extinguishment of debt
(7.0
)
 

 
(12.1
)
 

 
(19.1
)
Income before income taxes
1,240.0

 
835.4

 
1,499.7

 
(1,821.6
)
 
1,753.5

(Provision for) benefit from income taxes
152.9

 
(292.0
)
 
(188.1
)
 
(24.8
)
 
(352.0
)
Net income
1,392.9

 
543.4

 
1,311.6

 
(1,846.4
)
 
1,401.5

Net income attributable to noncontrolling interests

 

 
(8.6
)
 

 
(8.6
)
Net income attributable to CBI
$
1,392.9

 
$
543.4

 
$
1,303.0

 
$
(1,846.4
)
 
$
1,392.9

 
 
 
 
 
 
 
 
 
 
Comprehensive income attributable to CBI
$
1,583.7

 
$
543.2

 
$
1,498.0

 
$
(2,041.2
)
 
$
1,583.7

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Parent
Company
 
Subsidiary
Guarantors
 
Subsidiary
Nonguarantors
 
Eliminations
 
Consolidated
(in millions)
 
 
 
 
 
 
 
 
 
Condensed Consolidating Statement of Comprehensive Income for the Three Months Ended November 30, 2018
Sales
$
772.0

 
$
1,763.7

 
$
886.9

 
$
(1,262.0
)
 
$
2,160.6

Excise taxes
(89.8
)
 
(94.9
)
 
(3.3
)
 

 
(188.0
)
Net sales
682.2

 
1,668.8

 
883.6

 
(1,262.0
)
 
1,972.6

Cost of product sold
(530.4
)
 
(1,242.6
)
 
(490.5
)
 
1,260.9

 
(1,002.6
)
Gross profit
151.8

 
426.2

 
393.1

 
(1.1
)
 
970.0

Selling, general and administrative expenses
(153.9
)
 
(199.4
)
 
(65.8
)
 
5.6

 
(413.5
)
Operating income (loss)
(2.1
)
 
226.8

 
327.3

 
4.5

 
556.5

Equity in earnings of equity method investees and subsidiaries
373.5

 
0.7

 
167.7

 
(512.6
)
 
29.3

Unrealized net loss on securities measured at fair value

 

 
(163.9
)
 

 
(163.9
)
Interest income
0.5

 

 
3.9

 

 
4.4

Intercompany interest income
63.1

 
165.7

 
1.3

 
(230.1
)
 

Interest expense
(75.6
)
 
(0.4
)
 
(1.2
)
 

 
(77.2
)
Intercompany interest expense
(140.5
)
 
(49.2
)
 
(40.4
)
 
230.1

 

Loss on extinguishment of debt
(1.7
)
 

 

 

 
(1.7
)
Income before income taxes
217.2

 
343.6

 
294.7

 
(508.1
)
 
347.4

(Provision for) benefit from income taxes
85.9

 
(80.5
)
 
(37.6
)
 
(3.1
)
 
(35.3
)
Net income
303.1

 
263.1

 
257.1

 
(511.2
)
 
312.1

Net income attributable to noncontrolling interests

 

 
(9.0
)
 

 
(9.0
)
Net income attributable to CBI
$
303.1

 
$
263.1

 
$
248.1

 
$
(511.2
)
 
$
303.1

 
 
 
 
 
 
 
 
 
 
Comprehensive income attributable to CBI
$
101.8

 
$
263.1

 
$
46.8

 
$
(309.9
)
 
$
101.8

 
 
 
 
 
 
 
 
 
 
Condensed Consolidating Statement of Comprehensive Income for the Three Months Ended November 30, 2017
Sales
$
756.3

 
$
1,585.8

 
$
795.6

 
$
(1,156.0
)
 
$
1,981.7

Excise taxes
(89.2
)
 
(87.1
)
 
(3.5
)
 

 
(179.8
)
Net sales
667.1

 
1,498.7

 
792.1

 
(1,156.0
)
 
1,801.9

Cost of product sold
(537.9
)
 
(1,111.3
)
 
(397.4
)
 
1,155.0

 
(891.6
)
Gross profit
129.2

 
387.4

 
394.7

 
(1.0
)
 
910.3

Selling, general and administrative expenses
(130.8
)
 
(186.9
)
 
(108.1
)
 
5.1

 
(420.7
)
Operating income (loss)
(1.6
)
 
200.5

 
286.6

 
4.1

 
489.6

Equity in earnings of equity method investees and subsidiaries
551.7

 
8.8

 
122.1

 
(650.4
)
 
32.2

Unrealized net gain on securities measured at fair value and related activities

 


216.9

 

 
216.9

Interest income
0.1

 

 
0.1

 

 
0.2

Intercompany interest income
60.3

 
125.2

 
0.9

 
(186.4
)
 

Interest expense
(69.5
)
 
(0.4
)
 
(11.7
)
 

 
(81.6
)
Intercompany interest expense
(101.4
)
 
(48.7
)
 
(36.3
)
 
186.4

 

Loss on extinguishment of debt

 

 
(10.3
)
 

 
(10.3
)
Income before income taxes
439.6

 
285.4

 
568.3

 
(646.3
)
 
647.0

(Provision for) benefit from income taxes
53.2

 
(99.0
)
 
(102.8
)
 
(2.0
)
 
(150.6
)
Net income
492.8

 
186.4

 
465.5

 
(648.3
)
 
496.4

Net income attributable to noncontrolling interests

 

 
(3.6
)
 

 
(3.6
)
Net income attributable to CBI
$
492.8

 
$
186.4

 
$
461.9

 
$
(648.3
)
 
$
492.8

 
 
 
 
 
 
 
 
 
 
Comprehensive income attributable to CBI
$
371.2

 
$
188.2

 
$
338.6

 
$
(526.8
)
 
$
371.2

Condensed Consolidating Statement of Cash Flows
 
Parent
Company
 
Subsidiary
Guarantors
 
Subsidiary
Nonguarantors
 
Eliminations
 
Consolidated
(in millions)
 
 
 
 
 
 
 
 
 
Condensed Consolidating Statement of Cash Flows for the Nine Months Ended November 30, 2018
Net cash provided by (used in) operating activities
$
(18.5
)
 
$
628.5

 
$
1,363.9

 
$

 
$
1,973.9

 
 
 
 
 
 
 
 
 
 
Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
Investments in equity method investees and securities

 
(0.1
)
 
(4,077.2
)
 

 
(4,077.3
)
Purchases of property, plant and equipment
(23.4
)
 
(79.4
)
 
(517.5
)
 

 
(620.3
)
Purchases of businesses, net of cash acquired

 
(19.5
)
 
(25.8
)
 

 
(45.3
)
Proceeds from sale of unconsolidated investment

 

 
110.2

 

 
110.2

Proceeds from sales of assets
0.5

 
39.4

 
6.4

 

 
46.3

Net proceeds from intercompany notes
694.0

 

 

 
(694.0
)
 

Net investment in equity affiliates
(3,934.9
)
 
(11.1
)
 

 
3,946.0

 

Other investing activities

 

 
(0.9
)
 

 
(0.9
)
Net cash used in investing activities
(3,263.8
)
 
(70.7
)
 
(4,504.8
)
 
3,252.0

 
(4,587.3
)
 
 
 
 
 
 
 
 
 
 
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
Dividends paid to parent company

 

 
(36.5
)
 
36.5

 

Net contributions from equity affiliates

 
28.8

 
3,953.7

 
(3,982.5
)
 

Net proceeds from (repayments of) intercompany notes
206.9

 
(562.6
)
 
(338.3
)
 
694.0

 

Proceeds from issuance of long-term debt
3,645.6

 

 
12.0

 

 
3,657.6

Proceeds from shares issued under equity compensation plans
32.6

 

 

 

 
32.6

Purchases of treasury stock
(504.3
)
 

 

 

 
(504.3
)
Dividends paid
(417.9
)
 

 

 

 
(417.9
)
Principal payments of long-term debt
(6.2
)
 
(13.2
)
 
(25.9
)
 

 
(45.3
)
Payments of debt issuance costs
(33.3
)
 

 

 

 
(33.3
)
Net proceeds from (repayments of) short-term borrowings
359.7

 

 
(374.2
)
 

 
(14.5
)
Payments of minimum tax withholdings on stock-based payment awards

 
(12.8
)
 
(0.8
)
 

 
(13.6
)
Net cash provided by (used in) financing activities
3,283.1

 
(559.8
)
 
3,190.0

 
(3,252.0
)
 
2,661.3

 
 
 
 
 
 
 
 
 
 
Effect of exchange rate changes on cash and cash equivalents

 

 
(7.6
)
 

 
(7.6
)
 
 
 
 
 
 
 
 
 
 
Net increase (decrease) in cash and cash equivalents
0.8

 
(2.0
)
 
41.5

 

 
40.3

Cash and cash equivalents, beginning of period
4.6

 
4.4

 
81.3

 

 
90.3

Cash and cash equivalents, end of period
$
5.4

 
$
2.4

 
$
122.8

 
$

 
$
130.6

 
 
 
 
 
 
 
 
 
 
 
Parent
Company
 
Subsidiary
Guarantors
 
Subsidiary
Nonguarantors
 
Eliminations
 
Consolidated
(in millions)
 
 
 
 
 
 
 
 
 
Condensed Consolidating Statement of Cash Flows for the Nine Months Ended November 30, 2017
Net cash provided by (used in) operating activities
$
(315.2
)
 
$
1,060.7

 
$
722.9

 
$

 
$
1,468.4

 
 
 
 
 
 
 
 
 
 
Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
Investment in securities

 

 
(191.3
)
 

 
(191.3
)
Purchases of property, plant and equipment
(15.4
)
 
(83.9
)
 
(606.3
)
 

 
(705.6
)
Purchases of businesses, net of cash acquired

 
(70.9
)
 
(61.0
)
 

 
(131.9
)
Proceeds from sales of assets

 

 
1.2

 

 
1.2

Net proceeds from intercompany notes
134.5

 

 
2.8

 
(137.3
)
 

Net investments in equity affiliates
(1,350.6
)
 

 

 
1,350.6

 

Other investing activities
(6.2
)
 

 
(4.5
)
 

 
(10.7
)
Net cash used in investing activities
(1,237.7
)
 
(154.8
)

(859.1
)

1,213.3


(1,038.3
)
 
 
 
 
 
 
 
 
 
 
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
Dividends paid to parent company

 

 
(33.0
)
 
33.0

 

Net contributions from (returns of capital to) equity affiliates

 
(0.2
)
 
1,383.8

 
(1,383.6
)
 

Net proceeds from (repayments of) intercompany notes
(11.6
)
 
(871.9
)
 
746.2

 
137.3

 

Proceeds from issuance of long-term debt
3,990.4

 

 
2,027.5

 

 
6,017.9

Proceeds from shares issued under equity compensation plans
37.5

 

 

 

 
37.5

Purchases of treasury stock
(239.2
)
 

 

 

 
(239.2
)
Dividends paid
(301.1
)
 

 

 

 
(301.1
)
Principal payments of long-term debt
(2,116.6
)
 
(14.5
)
 
(4,391.7
)
 

 
(6,522.8
)
Payments of debt issuance costs
(28.9
)
 

 
(3.5
)
 

 
(32.4
)
Net proceeds from short-term borrowings
238.6

 

 
366.3

 

 
604.9

Payments of minimum tax withholdings on stock-based payment awards

 
(21.9
)
 
(1.0
)
 

 
(22.9
)
Net cash provided by (used in) financing activities
1,569.1

 
(908.5
)
 
94.6

 
(1,213.3
)
 
(458.1
)
 
 
 
 
 
 
 
 
 
 
Effect of exchange rate changes on cash
and cash equivalents

 

 
5.1

 

 
5.1

 
 
 
 
 
 
 
 
 
 
Net increase (decrease) in cash and cash equivalents
16.2

 
(2.6
)
 
(36.5
)
 

 
(22.9
)
Cash and cash equivalents, beginning of period
9.6

 
5.3

 
162.5

 

 
177.4

Cash and cash equivalents, end of period
$
25.8

 
$
2.7

 
$
126.0

 
$

 
$
154.5